Tag: Clots
2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism
Increase in PE diagnosis and higher proportion of low-risk PEs, with lower proportion of ICU admissions
Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
Risk of recurrent thrombotic events similar to that of patients with VTE linked to hospitalization for other acute medical illness
Outcomes Similar With Craniotomy, Craniectomy for Subdural Hematoma
Similar disability and quality-of-life outcomes seen with craniotomy, decompressive craniectomy for traumatic acute subdural hematoma
Young Adults, Children With Overweight Have Higher Risk for VTE in Adulthood
Individuals with young adult overweight, or overweight in childhood and young adult age have increased risk for VTE as adults
Venous Thromboembolism Risk Low in COVID-19 Outpatients
Patient-level factors, including age, sex, and body mass index, associated with higher risk
Use of Vena Cava Filters in VTE Patients Is Safe, Effective
Few adverse events seen, even in prophylactic use
Mechanical Thrombectomy Comparable to Best Medical Treatment for Rare Type of Stroke
Similar favorable functional outcomes seen for both thrombectomy and medical management in patients with distal medium vessel occlusion of anterior cerebral artery
In Diabetes, Women Have Higher Risk for Venous Thromboembolism
Significantly higher association between diabetes and VTE seen among women versus men, especially those aged 50 to 59 years
Network Meta-Analysis Compares DOACs to LMWH for Cancer-Linked Thrombosis
Apixaban dominated enoxaparin and edoxaban; rivaroxaban was slightly more effective than apixaban
Six Additional Weeks of Rivaroxaban Reduces Recurrent VTE
Risk for recurrent venous thromboembolism reduced for patients with isolated distal DVT receiving six additional weeks of rivaroxaban
